Skip to main navigation Skip to search Skip to main content

IL12RB1 Deficiency Appearing in North America: Expanding the Clinical Phenotypes

  • Chen Wang
  • , Beatriz E. Marciano
  • , Annalie J. Harris
  • , Alicia M. Johnston
  • , Evsen Apaydin Arikan
  • , Diana K. Bayer
  • , Benjamin D. Solomon
  • , Nathan B. Price
  • , Craig D. Platt
  • , Arunkumar J. Modi
  • , Marcus S. Shaker
  • , Christine M. Seroogy
  • , Daniel Johnson
  • , David E. Kleiner
  • , Lavenda Chirombo Kluczynski
  • , Victoria L. Anderson
  • , Janine R. Daub
  • , Joanne Berghout
  • , Andrew J. Oler
  • , Magdalena A. Walkiewicz
  • Morgan Similuk, David B. Lewis, John N. Galgiani, Alexandra F. Freeman, Lindsey B. Rosen, Amy P. Hsu, Christa S. Zerbe, Steven M. Holland

Research output: Contribution to journalArticlepeer-review

Abstract

Interleukin-12 receptor β1 (IL-12Rβ1) deficiency is the most common genetic form of Mendelian susceptibility to mycobacterial disease globally, often presenting as disseminated Bacillus Calmette-Guérin (BCG) infection. In North America, however, where BCG is not used, it manifests with other bacterial or fungal infections, highlighting distinct, sometimes unrecognized, presentations of IL-12Rβ1 deficiency in this geographic area.

Original languageEnglish (US)
Pages (from-to)e328-e331
JournalClinical Infectious Diseases
Volume82
Issue number2
DOIs
StatePublished - Feb 15 2026

Keywords

  • Bordetella hinzii
  • Burkholderia vietnamiensis
  • IL-12Rβ1
  • blastomycosis
  • coccidioidomycosis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'IL12RB1 Deficiency Appearing in North America: Expanding the Clinical Phenotypes'. Together they form a unique fingerprint.

Cite this